Sun Pharma Share Price: Alarm For Indian Pharmaceutical Company Manufacturing and Selling Pharmaceutical Formulations and Active Pharmaceutical Ingredients in India and the United States!

Subscribe 

Sun Pharma Share Price

Sun Pharma Share Price: Alarm For Indian Pharmaceutical Company Manufacturing and Selling Pharmaceutical Formulations and Active Pharmaceutical Ingredients in India and the United States!

Sun Pharma share price today is 689.25 USD with a volume of 2,724,983. At the same time, its chart fluctuates between 673.90 USD – 691.60 USD. Sun Pharma share price was a maximum of 721.85 USD and a minimum of 452.25 USD within 52 weeks.  Its average volume is 3,179,647 and it is ranked 162.303 in the MarketCap listings. The target point of Sun Pharma share price at the end of 1 year is not clear yet. The face value of the stock is 1 and its book value per share is 206,22. Its UC limit is 758.15 and the LC limit is 620.35.

 

Sun Pharma Share on the Last Trading Day

Sun Pharma Share on the Last Trading Day

Sun Pharma share price rose 0.0944% on the last trading day. The price increased from $688.60 to $689.25. Today is the 3rd day that the stock gains in a row. We will see if it will continue its 3-day rise in the coming period. During the day, the stock fluctuated 1.98% from the day’s low of $678.05 to the day’s high of $691.50. The price was up 7 of the last 10 days. In the last 2 weeks, it has experienced a total increase of 1.33%.

Volume fell by 2 million shares in the last day, with a total of 2 million shares traded for approximately $1.34 billion. While prices are increasing in this way, the decrease in volume is technically negative. The opposite trend of volume and prices can be an early warning risk. Also, this confrontation increases the risk.

Sun Pharma share price is in the middle of a weak uptrend in the short term. Also, we are getting more bullish signals within the trend. Considering the current short-term trend, the stock could rise 2.58% over the next 3 months. At the end of this 3-month period, it can hold a price between $687.02 and $733.28.

 

What Level Is the Stock in the Short and Long Term?

When we examine the Sun Pharma share price chart today, we see mostly positive signals. The stock has to buy signals from both short-term and long-term moving averages that give a positive forecast for the stock. Also, the short-term average is above the long-term average. Therefore, there is a general buy signal from the relationship between the two signals.

During the decline, we see some support from the lines at $680.89 and $675.13. Falling below any of these levels will give sell signals. We received a buy signal from the pivot low on June 24, 2021. On top of that, we have observed an increase of 3.68% so far. There could be more upsides until we catch a new upper pivot signal. Also, the stock has a buy signal at the 3-month Moving Average Convergence Divergence.

Volume fell despite rising prices on the last trading day. The divergence between volume and price increases the risk. Also, this is not a positive result in terms of technical analysis.

Sun Pharma Share Support Level and Beyond

Sun Pharma Share Support Level and Beyond

Analyzing the chart for Sun Pharma share price, we see support at $683.30, from the accumulated volume. We expect an upside reaction as support is tested so we don’t see a risk of it falling below support. This support can present a good buying opportunity.

In general, the stock moves control during the day. With good liquidity, we can consider the risk very low in this stock. Over the last day, the stock has moved between the high and low at $13.45 and 1.98%. Last week, the stock moved 1.92% on a daily basis.

 

Should You Buy?

Overall, the stock has a good trend and a few positive features. The current level could hold a buying opportunity for Sun Pharma share price to perform well in the short term. The stop-loss that analysts recommend for this stock $653.97. The daily volatility of this stock is low. This means low risk.

Views:
340
Article Categories:
INVESTING

Comments are closed.